Cover Feature: How Clavulanic Acid Inhibits Serine β‐Lactamases (ChemBioChem 22/2024)

Pauline A. Lang,Mariska de Munnik,Abraham O. Oluwole,Timothy D. W. Claridge,Carol V. Robinson,Jürgen Brem,Christopher J. Schofield
DOI: https://doi.org/10.1002/cbic.202482202
IF: 3.2
2024-11-24
ChemBioChem
Abstract:Clavulanic acid is a densely functionalized low mass (C8H9NO5) drug, which is used to protect penicillins and other β‐lactam antibiotics from hydrolysis by serine β‐lactamases. As shown by detailed mass spectrometric analyses, clavulanic acid reacts covalently with serine β‐lactamase to form an initial acyl‐enzyme complex which, like the analogous complex formed with β‐lactam antibiotics, can undergo hydrolysis. In the case of clavulanic acid, however, the acyl‐enzyme complex also undergoes competing fragmentation to give inhibitory complexes stable to hydrolysis. More details can be found in article 10.1002/cbic.202400280 by Christopher J. Schofield and co‐workers.
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?